Bioxyne Signs Manufacturing Agreement with Aurora Cannabis
Filed with ASX · · 4 pages · English
Summary by 6ix AI
The agreement includes the supply of GMP-certified medicinal cannabis oils and plans to expand into cannabis vapes for markets in Australia, the UK, and Germany. This partnership highlights Bioxyne's capabilities in pharmaceutical-grade cannabis manufacturing and positions it as a trusted supplier internationally.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Story so far
Earlier from Bioxyne
- BXN H1 FY2026 Results Presentation
- Stronger H1 FY2026 Performance Upward Revision to Guidance
- Half Yearly Report and Accounts
- Presentation Results Q2 FY2026
- Appendix 4C Revised
Later from Bioxyne
- Manufacturing Agreement Aurora Supplementary Information
- Expands LATAM Footprint First Supply Agreement Costa Rica
- Secures $50m Exclusive German Supply Agreement with ADREX
- Notice of General Meeting/Proxy Form
Follow Bioxyne into a list and get an email when it puts out news.
Follow Bioxyne